Ergomed update underlines the potential of the company's PrimeVigilance unit
According to one City number cruncher, Ergomed’s drugs safety unit alone is worth as much as the whole business
Company
Ergomed PLC
LON:ERGO
Ergomed PLC provides specialist services to the pharmaceutical industry spanning all phases of clinical development, post-approval pharmacovigilance and medical information. The company's fast-growing services business includes an industry-leading suite of specialist pharmacovigilance (PV) solutions, integrated under the PrimeVigilance brand and a full range of high-quality clinical research and trial management services under the Ergomed brand (CRO).
204 stories · page 5 of 11
Investments and investor services
Smith & Nephew tops the Footsie after upgrade from JP Morgan Cazenove
Further down the food chain, Avacta, the company behind the Affirma technology - small, engineered proteins that are capable of binding specific molecular targets - got a lift from a research report by Capital Network.
Ergomed ready to kick on after a strong year
The pharma services and drug development company posted total sales of £47mln for the period to December 31, up 21%, while net service revenues were ahead 35% at £39mln
Investments and investor services
FTSE 100 closes lower as Euro gains ground
Britain's blue-chip benchmark finished around 27 points lower at 7,615.
Archive
Proactive news snapshot: Ortac Resources, Ceres Power Holdings, Bacanora Minerals …
A glance at some of the day's highlights from the Proactive Investors newswire
Ceres Power Holdings surges as market cheers update
We take a look at some of the major movers - risers and fallers - in London on Friday.
Ergomed's finance chief appointed chief executive; welcomes new COO
Stamp has held senior roles at a number of healthcare businesses in the UK and US, the firm said
FTSE 100 ends at high point of the day but just short of 7,500
A slump in the value of the pound was, as usual, a signal for investors to pile into FTSE 100 stocks
Archive
Proactive news snapshot: ValiRx, W Resources, Falcon Oil & Gas …
A glance at some of the day's highlights from the Proactive Investors newswire
Surprise trading update is just the job for Robert Walters
The trading update was short and sweet. Liberum responded by increasing its target price.
Allergy Therapeutics teams up with Ergomed to take its anti-allergy tablets through the clinic
Allergy already has injectable vaccines for dust mites and tree and grass pollen, but it has brought in Ergomed to take the tablet formulations through clinical trials
FTSE 100 closes higher as energy stocks provide a boost; supermarkets weigh
Robert Walters sprang a pleasant surprise on the market with an unscheduled trading update.
Archive
Proactive news snapshot: Alliance Pharma, TyraTech, Galileo Resources …
A glance at some of the day's highlights from the Proactive Investors newswire
Investments and investor services
Elegant Hotels rejects bid approach from Melia Hotels
By the time it has confirmed press speculation, the bid approach was a dead duck
Ergomed to present at the International Society of Pharmacovigilance's Intelligent Automation
Can automated processes powered by artificial intelligence provide effective solutions to the ever-increasing challenges in pharmacovigilance?
FTSE 100 closes higher; miners lag and Brexit wranglings continue
FTSE 100 closed over 38 points higher on the day to 7,338; FTSE 250 shares added over 81
Archive
Proactive news snapshot: Premier African Minerals, Ergomed, ANGLE …
A glance at some of the day's highlights from the Proactive Investors newswire
Ergomed hopes to have PeproStat on the market by 2020 as it sails through Phase II trials
“We are delighted to report positive results from the Phase II study. We believe PeproStat is a first-in-class product which could enter the large and growing haemostat market as early as 2020.”
Ergomed PSR acquisition seen as a “good fit”
Numis rates Ergomed a 'buy' with a 280p target price